Vasonatrin peptide: A unique synthetic natriuretic and vasorelaxing peptide

Chi Ming Wei, Cheol H. Kim, Virginia M Miller, John C Jr. Burnett

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

This study reports the cardiovascular and renal actions of a novel and newly synthesized 27-amino acid peptide termed vasonatrin peptide (VNP). VNP is a chimera of atrial natriuretic peptide (ANP) and C-type natriuretic peptide (CNP). This synthetic peptide possesses the 22-amino acid structure of CNP, which is a cardiovascular selective peptide of endothelial origin and is structurally related to ANP. VNP also possesses the five-amino acid COOH terminus of ANP. The current study demonstrates both in vitro and in vivo that VNP possesses the venodilating actions of CNP, the natriuretic actions of ANP, and unique arterial vasodilating actions not associated with either ANP or CNP.

Original languageEnglish (US)
Pages (from-to)2048-2052
Number of pages5
JournalJournal of Clinical Investigation
Volume92
Issue number4
StatePublished - 1993

Fingerprint

Natriuretic Peptides
C-Type Natriuretic Peptide
Atrial Natriuretic Factor
Amino Acids
Peptides
eel ventricular natriuretic peptide
peptide A
Kidney

Keywords

  • Cardiorenal function
  • Cgmp
  • Endothelium
  • Natriuretic peptide
  • Vasorelaxation

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Vasonatrin peptide : A unique synthetic natriuretic and vasorelaxing peptide. / Wei, Chi Ming; Kim, Cheol H.; Miller, Virginia M; Burnett, John C Jr.

In: Journal of Clinical Investigation, Vol. 92, No. 4, 1993, p. 2048-2052.

Research output: Contribution to journalArticle

@article{bb76dbdbe0364bd1a05379812b6d697e,
title = "Vasonatrin peptide: A unique synthetic natriuretic and vasorelaxing peptide",
abstract = "This study reports the cardiovascular and renal actions of a novel and newly synthesized 27-amino acid peptide termed vasonatrin peptide (VNP). VNP is a chimera of atrial natriuretic peptide (ANP) and C-type natriuretic peptide (CNP). This synthetic peptide possesses the 22-amino acid structure of CNP, which is a cardiovascular selective peptide of endothelial origin and is structurally related to ANP. VNP also possesses the five-amino acid COOH terminus of ANP. The current study demonstrates both in vitro and in vivo that VNP possesses the venodilating actions of CNP, the natriuretic actions of ANP, and unique arterial vasodilating actions not associated with either ANP or CNP.",
keywords = "Cardiorenal function, Cgmp, Endothelium, Natriuretic peptide, Vasorelaxation",
author = "Wei, {Chi Ming} and Kim, {Cheol H.} and Miller, {Virginia M} and Burnett, {John C Jr.}",
year = "1993",
language = "English (US)",
volume = "92",
pages = "2048--2052",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "4",

}

TY - JOUR

T1 - Vasonatrin peptide

T2 - A unique synthetic natriuretic and vasorelaxing peptide

AU - Wei, Chi Ming

AU - Kim, Cheol H.

AU - Miller, Virginia M

AU - Burnett, John C Jr.

PY - 1993

Y1 - 1993

N2 - This study reports the cardiovascular and renal actions of a novel and newly synthesized 27-amino acid peptide termed vasonatrin peptide (VNP). VNP is a chimera of atrial natriuretic peptide (ANP) and C-type natriuretic peptide (CNP). This synthetic peptide possesses the 22-amino acid structure of CNP, which is a cardiovascular selective peptide of endothelial origin and is structurally related to ANP. VNP also possesses the five-amino acid COOH terminus of ANP. The current study demonstrates both in vitro and in vivo that VNP possesses the venodilating actions of CNP, the natriuretic actions of ANP, and unique arterial vasodilating actions not associated with either ANP or CNP.

AB - This study reports the cardiovascular and renal actions of a novel and newly synthesized 27-amino acid peptide termed vasonatrin peptide (VNP). VNP is a chimera of atrial natriuretic peptide (ANP) and C-type natriuretic peptide (CNP). This synthetic peptide possesses the 22-amino acid structure of CNP, which is a cardiovascular selective peptide of endothelial origin and is structurally related to ANP. VNP also possesses the five-amino acid COOH terminus of ANP. The current study demonstrates both in vitro and in vivo that VNP possesses the venodilating actions of CNP, the natriuretic actions of ANP, and unique arterial vasodilating actions not associated with either ANP or CNP.

KW - Cardiorenal function

KW - Cgmp

KW - Endothelium

KW - Natriuretic peptide

KW - Vasorelaxation

UR - http://www.scopus.com/inward/record.url?scp=0027448795&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027448795&partnerID=8YFLogxK

M3 - Article

C2 - 8408658

AN - SCOPUS:0027448795

VL - 92

SP - 2048

EP - 2052

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 4

ER -